HENWOOD GERALDINE 4
4 · Recro Pharma, Inc. · Filed Jan 5, 2021
Insider Transaction Report
Form 4
HENWOOD GERALDINE
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2021-01-02$3.09/sh−5,599$17,301→ 201,467 total
Holdings
- 50,000(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.